Drugs for Hydatidiform Mole, Recurrent, 1 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 39)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Nitroglycerin |
Approved, Investigational |
Phase 4,Phase 2 |
|
55-63-0 |
4510
|
Synonyms:
1,2,3-Propanetrioltrinitrate
1,2,3-Propanetrioltrinitric acid
1,2,3-Propanetriyl nitrate
1,2,3-Propanetriyl nitric acid
100292-13-5
105469-31-6
55-63-0
80066-48-4
8013-23-8
9010-02-0
AC1L1IBV
Adesitrin
Aldonitrin
Angibid
Anginine
Angiolingual
Angiplex
Anglix
Angonist
Angorin
Anogesic
Aquo-Trimitrosan
BIDD:GT0142
Blasting gelatin
Blasting oil
BRN 1802063
Buccal
Buccard
c0061
C07455
C3H5N3O9
Cardabid
Cardamist
Cardinit
Cardiodisco
CCRIS 4089
Cellegesic
CHEBI:28787
CHEMBL730
Chitamite
CID4510
Colenitral
Cordipatch
Corditrine
Coro-Nitro
CPD-143
D00515
D005996
Dauxona
DB00727
Deponit
Deponit 5
Deponit TTS 10
Deponit TTS 5
Deponit-5
Diafusor
Discotrine
Dynamite
EINECS 200-240-8
Epinitril
Gepan Nitroglicerin
Gilucor nitro
Gilustenon
Glonoin
Glycerin trinitrate
Glycerin trinitric acid
Glycerine trinitrate
Glycerintrinitrate
Glycerol trinitrate
Glycerol trinitric acid
Glycerol, nitrate triester
Glycerol, nitric acid triester
Glyceroli trinitratis
Glyceroltrinitraat
Glyceroltrinitrat
Glyceryl
Glyceryl nitrate
Glyceryl trinitrate
Glyceryl trinitric acid
Glycerylnitrat
Glytrin
GTN
GTN-Pohl
Herwicard
Herzer
HMS2094M15
HSDB 30
IMX-150
Klavikordal
Lenitral
Lentonitrina
LS-7741
MED-2002
Millisrol
Minitram
Minitran
Minitran (TN)
Minitro
Mionitrat
Mi-Trates
MQX-503
Myocon
Myoglycerin
Myovin
Natispray
Neos nitro OPT
NG
Niglin
Niglycon
Niong
Niong Retard
Nirmin
Nitora
Nitradisc
Nitradisc Pad
Nitradisc TTS
Nitrangin
Nitrek
Nit-Ret
Nitriderm
Nitriderm TTS
Nitrine-TDC
nitro Bid
Nitro Bid
nitro Dur
Nitro Dur
Nitro Dur TTS
NITRO IV
Nitro Mack Retard
Nitro Retard
Nitro Rorer
Nitroard
Nitrobaat
nitro-Bid
NitroBid
Nitro-Bid
Nitro-bid (TN)
Nitrobid Oint
Nitrobukal
Nitrocap
NitrocapT.D
NitrocapT.D.
Nitrocard
Nitrocerin
Nitrocine
Nitrocine 5
Nitroclyn
|
Nitrocontin
Nitrocontin Continus
NitroCor
Nitrocot
Nitroderm
Nitroderm TTS
Nitroderm TTS Ext
Nitroderm TTS-5
Nitrodisc
nitro-Dur
Nitro-dur
NitroDur
Nitro-dur (TN)
Nitro-Dur 10
Nitro-Dur 5
Nitrodyl
Nitrodyl TTS
Nitrogard
Nitrogard-SR
Nitro-Gesanit Retard
Nitroglicerina
Nitrogliceryna
Nitroglin
nitroglycerin
Nitroglycerin
Nitroglycerin (NG)
Nitroglycerin ointment
Nitroglycerin-ACC
Nitroglycerine
Nitroglycerol
Nitroglyn
Nitroject
Nitrol
Nitrol Ointment
Nitrolan
Nitro-lent
Nitroletten
Nitrolin
Nitrolingual
Nitrolingual Spray
Nitrolowe
Nitromack Retard
Nitro-Mack Retard
Nitro-M-Bid
Nitromed
Nitromel
Nitromex
Nitromint
Nitromint Aerosol
Nitromint Retard
Nitromist
NitroMist
Nitromist (TN)
Nitronal Aqueous
Nitronet
Nitrong
Nitrong parenteral
Nitrong Retard
Nitrong-SR
Nitro-Par
Nitropatch
Nitropen
Nitropercuten
Nitroperlinit
Nitro-Pflaster
Nitroplast
Nitroprol
Nitropront
Nitroprontan
NitroQuick
NitroQuik
Nitrorectal
Nitroretard
Nitrorex
Nitrospan
Nitro-Span
Nitrostabilin
Nitrostat
Nitro-Time
Nitrovis
Nitrozell retard
NK-843
NTG
Nysconitrine
Percutol
Percutol Oint
Percutol Oint.
Perganit
Perglottal
Perlinganit
Plastranit
Polnitrin
Propane-1,2,3-triyl trinitrate
Propane-1,2,3-triyl trinitric acid
Ratiopharm
RCRA waste no. P081
Rectogesic
SDM No. 17
SK-106N
SK-866
SK-878
Soup
Spirit of glonoin
Susadrin
Suscard
Sustac
Sustak
Sustonit
Temponitrin
TNG
Top-Nitro
Transderm nitro
Transderm Nitro
Transderm-N TTS
Transderm-nitro
Transderm-nitro (TN)
Transderm-Nitro TTS
Transiderm-nitro
Tridil
Tridil sublin
Trinalgon
Trinipatch
Triniplas
Trinitrate, glyceryl
Trinitrate, Glyceryl
Trinitrin
Trinitrin Tablets
Trinitrina Erba
Trinitrine
Trinitroglycerin
Trinitroglycerol
Trinitrol
Trinitrolong
Trinitron
Trinitrosan
Turicard
UN0143
UN0144
UN1204
UN3064
UN3319
UNII-G59M7S0WS3
Vascana
Vasoglyn
Vasolator
Vernies
Willong
|
|
2 |
|
leucovorin |
Approved |
Phase 3,Phase 2 |
|
58-05-9 |
6006
143
|
Synonyms:
(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate
(6R,S)-5-Formyltetrahydrofolate
10-Formyl-7,8-dihydrofolate
10-Formyl-7,8-dihydrofolic acid
5 Formyltetrahydrofolate
5 Formyltetrahydropteroylglutamate
5-Formyl-5,6,7,8-tetrahydrofolate
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid
5-Formyltetrahydrofolate
5-formyltetrahydrofolic acid
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
Acid, folinic
Acide folinique
Calcium citrovorum factor
Calcium folinate
Calcium leucovorin
Citrovorum factor
Factor, citrovorum
folinate
Folinate
Folinate, calcium
Folinic acid
Folinic acid calcium salt
Folinic acid calcium salt USP27
Folinic acid SF
Folinic acid-SF
L(-)-5-Formyl-5,6,7,8-tetrahydrofolate
|
L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid
Leucal
Leucovorin
Leucovorin calcium
Leucovorin folinic acid
Leucovorin, (D)-isomer
Leucovorin, (DL)-isomer
Leucovorin, (R)-isomer
Leucovorin, calcium
Leucovorin, calcium (1:1) salt
Leucovorin, calcium (1:1) salt, (DL)-isomer
Leucovorin, calcium (1:1) salt, pentahydrate
Leucovorin, monosodium salt
Leucovorinum
Leukovorin
Leukovorum
Levoleucovorin
L-leucovorin
L-Leucovorin
L-N-[P-[[(2-amino-5-Formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-glutamic acid
Monosodium salt leucovorin
N(5)-Formyltetrahydrofolate
N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolate
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyltetrahydrofolate
N5-Formyltetrahydrofolic acid
Rescuvolin
Welcovorin
Wellcovorin
|
|
3 |
|
Methotrexate |
Approved |
Phase 3,Phase 2 |
|
59-05-2, 1959-05-2 |
126941
|
Synonyms:
4-amino-10-Methylfolate
4-amino-10-methylfolic acid
4-amino-10-Methylfolic acid
4-amino-N(10)-Methylpteroylglutamate
4-amino-N(10)-methylpteroylglutamic acid
4-amino-N(10)-Methylpteroylglutamic acid
Abitrexate
Amethopterin
Amethopterine
Antifolan
Arbitrexate
Dicesium salt methotrexate
Emtexate
Emtexic acid
Folex
HDMTX
Hydrate, methotrexate
L-Amethopterin
Ledertrexate
Ledertrexic acid
Metatrexan
Methopterin
Methotextrate
Methotrate
Methotrexat
|
Méthotrexate
Methotrexate hydrate
Methotrexate sodium
Methotrexate Sodium
Methotrexate, (D)-isomer
Methotrexate, (DL)-isomer
Methotrexate, dicesium salt
Methotrexate, disodium salt
Methotrexate, sodium salt
Methotrexatum
Methotrexic acid
Methylaminopterin
Methylaminopterinum
Metotrexato
Mexate
MTX
N-[4-[[(2,4-diamino-6-Pteridinyl)methyl]methylamino]benzoyl]-L-glutamate
N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
N-[4-[[(2,4-diamino-6-Pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
N-Bismethylpteroylglutamic acid
N-Bismethylpteroylglutamic Acid
Rheumatrex
Sodium, methotrexate
Trexall
|
|
4 |
|
Dactinomycin |
Approved, Investigational |
Phase 3 |
|
50-76-0 |
457193
2019
|
Synonyms:
(- )-actinomycin d
(-)-actinomycin d
01815_FLUKA
1H-Pyrrolo(2,1-1)-(1,4,7,10,13)oxatetraazacyclohexadecine
2-amino-N,N'-bis(hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-i)(1,4,7,10,13)oxatetra-azacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide
2-amino-N,N'-bis(hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-I)(1,4,7,10,13)oxatetra-azacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide
4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide
50-76-0
A1410_SIGMA
A4262_SIGMA
A9415_SIGMA
AC1L1CQX
AC1L9W52
Ac-de
ACon0_000471
ACon1_001004
ACT D
Actactinomycin A IV
ActD
Actinomycin
Actinomycin 11 cosmegen
Actinomycin 7
Actinomycin A IV
Actinomycin Aiv
Actinomycin C (sub1)
Actinomycin C(sub1)
Actinomycin C1
actinomycin cl
actinomycin D
Actinomycin D
ACTINOMYCIN D AMP
Actinomycin D (JP15)
Actinomycin D deriv. of 3H-phenoxaocardazine
Actinomycin D, sodium deoxyribonucleic acid complex
Actinomycin I
Actinomycin I (sub1)
Actinomycin I(sub 1)
Actinomycin I(sub1)
Actinomycin I1
Actinomycin iv
Actinomycin IV
Actinomycin X 1
actinomycin x i
Actinomycin X1
Actinomycin-(threo-val-pro-sar-meval)
Actinomycin-?IV
Actinomycin-[threo-val-pro-sar-meval]
ACTINOMYCIN-D
Actinomycindioic D acid, dilactone
actinomyein-theo-val-pro-sar-meval
Acto-D
AD (VAN)
AI3-26374
Antibiotic from Streptomyces parvullus
BCBcMAP01_000155
Bio1_000342
Bio1_000831
Bio1_001320
BRD-A42383464-001-02-2
C06770
C1
C62H86N12O16
CBiol_002056
CCRIS 9
CHEBI:123721
CHEBI:27666
CHEMBL1554
CHEMBL427947
Chounghwamycin B
CID2019
CID457193
|
Cosmegen
COSMEGEN (TN)
Cosmegen lyovac
CPD000469227
D Actinomycin
D00214
Dactinomicina
Dactinomicina [INN-Spanish]
Dactinomycin
DACTINOMYCIN
Dactinomycin (USP)
Dactinomycin [USAN:BAN]
Dactinomycin D
Dactinomycine
Dactinomycine [INN-French]
Dactinomycinum
Dactinomycinum [INN-Latin]
dactinomyein d
DB00970
Dilactone actin omycindioic D acid
Dilactone actinomycin D acid
Dilactone actinomycindioic D acid
DVA-DPR-SAR-MVA-(c1)DTH-PXZ-(c11)DTH-DVA-DPR-SAR-MVA
EINECS 200-063-6
FT-0080366
GNF-PF-1977
HBF 386
HBF 386 meractinomycin
HMS2052O17
HSDB 3220
Lemery brand OF dactinomycin
LMPK14000005
LS-142
Lyovac cosmegen
Lyovac, cosmegen
Lyovac-cosmegen
MEGxm0_000350
Meractinomycin
Merck brand OF dactinomycin
Merck frosst brand OF dactinomycin
Merck sharp and dohme brand OF dactinomycin
MLS001424196
MolPort-001-739-741
MolPort-003-925-177
MSD Brand OF dactinomycin
NCGC00025059-02
NCGC00090796-01
NCGC00161622-01
NCGC00161622-02
NCGC00169767-01
NCI60_030539
NCI-C04682
Neuro_000003
NP-005932
NSC 3053
NSC191297
NSC3053
NSC-3053
o)-(1-oxo-1,2-ethanediyl)]bis(N-methyl)L-valine
Oncostatin K
-pentone
PXZ-THR-DVA-PRO-SAR-MVA-THR-DVA-PRO-SAR-MVA
SAM001246846
SMP1_000005
SMR000469227
UNII-1CC1JFE158
UPCMLD-DP055
UPCMLD-DP055:001
UPCMLD-DP055:002
WLN: 16- AN FVN IVN LVO PVM SVTJ G1 J1 KY1&1 N1 RY1&1
X 97
|
|
5 |
|
Amifostine |
Approved, Investigational |
Phase 3 |
|
20537-88-6 |
2141
|
Synonyms:
Alza brand OF amifostine
Amifostina
Amifostine alza brand
Amifostine anhydrous
Amifostine disodium salt
Amifostine essex brand
Amifostine ethiofos
Amifostine lilly brand
Amifostine monohydrate
Amifostine monohydrochloride
Amifostine schering-plough brand
Amifostine trihydrate
Amifostinum
Aminopropyl aminoethylthiophosphate
Aminopropylaminoethyl thiophosphate
Aminopropylaminoethylthiophosphate
Aminopropylaminoethylthiophosphoric acid
Anhydrous, amifostine
|
Anhydrous, ethiofos
Apaetp
Disodium salt, amifostine
Essex brand OF amifostine
Ethiofos
Ethiofos anhydrous
Ethyol
Gammaphos
Lilly brand OF amifostine
Monohydrate, amifostine
Monohydrochloride, amifostine
S-(N-(3-Aminopropyl)-2-aminoethyl)thiophosphoric acid
SAPEP
Schering plough brand OF amifostine
Schering-plough brand OF amifostine
Trihydrate, amifostine
US bioscience brand OF amifostine
WR-1065
|
|
6 |
|
Levoleucovorin |
Approved, Investigational |
Phase 3,Phase 2 |
|
68538-85-2 |
|
Synonyms:
(6S)-5-Formyl-5,6,7,8-tetrahydrofolic acid
(6S)-5-formyltetrahydrofolic acid
(6S)-Folinic acid
(6S)-Leucovorin
(S)-Leucovorin
|
Citrovorum factor
Levofolene
Levofolinic acid
L-Folinic acid
N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid
|
|
7 |
|
Folic Acid |
Approved, Nutraceutical, Vet_approved |
Phase 3,Phase 2 |
|
59-30-3 |
6037
|
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
AI3-26387
AKOS000503224
Antianemia factor
Apo-Folic
ARONIS014410
b9, Vitamin
BIDD:ER0563
BIDD:GT0641
BIF0608
bmse000299
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat b activ
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
Facid
Factor U
FOL
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folic acid, (D)-isomer
Folic acid, (DL)-isomer
Folic acid, calcium salt (1:1)
Folic acid, monopotassium salt
Folic acid, monosodium salt
Folic acid, potassium salt
Folic acid, sodium salt
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
|
Folsaeure
Folsan
Folsaure
Folsäure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
Incafolic
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
Liver lactobacillus casei factor
Liver Lactobacillus casei factor
LS-2157
Millafol
Mission prenatal
Mittafol
MLS001304016
MLS001335861
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamate
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-amino-3,4-dihydro-4-oxo-6-Pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
nchembio.108-comp10
Nifolin
Nifolin [Denmark]
NINDS_000494
Novofolacid
Novofolacid [Canada]
N-Pteroyl-L-glutamate
N-pteroyl-L-glutamic acid
N-Pteroyl-L-glutamic acid
NSC 3073
PGA
PGA (VAN)
Prestwick_230
Prestwick3_000627
PteGlu
Pteroylglutamate
Pteroylglutamic acid
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
Serum Folate Level
SMP2_000137
SMR000471860
SPBio_001357
Spectrum_001381
SPECTRUM1502020
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin b9
Vitamin B9
Vitamin Bc
Vitamin BC
Vitamin be
Vitamin Be
Vitamin m
Vitamin M
|
|
8 |
|
Nucleic Acid Synthesis Inhibitors |
|
Phase 3,Phase 2 |
|
|
|
9 |
|
Vitamin B9 |
|
Phase 3,Phase 2 |
|
|
|
10 |
|
Immunologic Factors |
|
Phase 3,Phase 2 |
|
|
|
11 |
|
Liver Extracts |
|
Phase 3 |
|
|
|
12 |
|
Vitamin B Complex |
|
Phase 3,Phase 2 |
|
|
|
13 |
|
Immunosuppressive Agents |
|
Phase 3,Phase 2 |
|
|
|
14 |
|
Folic Acid Antagonists |
|
Phase 3,Phase 2 |
|
|
|
15 |
|
Micronutrients |
|
Phase 3,Phase 2 |
|
|
|
16 |
|
Antirheumatic Agents |
|
Phase 3,Phase 2 |
|
|
|
17 |
|
Antimetabolites |
|
Phase 3,Phase 2 |
|
|
|
18 |
|
Folate |
|
Phase 3,Phase 2 |
|
|
|
19 |
|
Hematinics |
|
Phase 3,Phase 2 |
|
|
|
20 |
|
Trace Elements |
|
Phase 3,Phase 2 |
|
|
|
21 |
|
Vitamins |
|
Phase 3,Phase 2 |
|
|
|
22 |
|
Antimetabolites, Antineoplastic |
|
Phase 3,Phase 2 |
|
|
|
23 |
|
Dermatologic Agents |
|
Phase 3,Phase 2 |
|
|
|
24 |
|
Anti-Bacterial Agents |
|
Phase 3 |
|
|
|
25 |
|
Antibiotics, Antitubercular |
|
Phase 3 |
|
|
|
26 |
|
Anti-Infective Agents |
|
Phase 3 |
|
|
|
27 |
|
Radiation-Protective Agents |
|
Phase 3 |
|
|
|
28 |
|
Protective Agents |
|
Phase 3,Phase 2 |
|
|
|
29 |
|
Bone Density Conservation Agents |
|
Phase 3,Phase 2 |
|
|
|
30 |
|
Calcium, Dietary |
|
Phase 3 |
|
|
|
31 |
|
Antidotes |
|
Phase 3,Phase 2 |
|
|
|
32 |
|
Pemetrexed |
Approved, Investigational |
Phase 2 |
|
150399-23-8, 137281-23-3 |
446556
60843
|
Synonyms:
(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid
(2S)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid
137281-23-3
150399-23-8
1juj
2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid
2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-PENTANEDIOIC ACID
AC1L1U1D
AC1L2PDW
AC1L98DY
AC1L9JT6
AC1OCF51
AC1Q5R1W
Alimta
ALIMTA
Alimta (TN)
Bio-0078
C20H19N5O6.2Na
C20H21N5O6
CHEBI:195145
CHEBI:43746
CHEBI:474008
CHEMBL1200373
CHEMBL225072
CHEMBL59843
CID125891
CID394493
CID446556
CID60843
CID6918197
D03828
D07472
DB00642
disodium (2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate
disodium (2S)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate
Disodium N-(p-(2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo(2,3-d)pyrimidin-5-yl)ethyl)benzoyl)-L-glutamate
|
Disodium, pemetrexed
HSDB 7316
I06-1253
I06-1294
I06-2128
L-Glutamic acid, N-(4-(2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo(2,3-d)pyrimidin-5-yl)ethyl)benzoyl)-, disodium salt
LS-172988
LS-173384
LY 231,514
LY 231514
LY-231,514
LY-2315
LY231514
LY-231514
LY231514 disodium
LYA
MTA
N-(4-(2-(2-amino-3,4-dihydro-4-oxo-7H-pyrrolo(2,3-D)Pyrimdin-5-yl)ethyl)benzoyl)glutamic acid
N-(4-(2-(2-Amino-3,4-dihydro-4-oxo-7H-pyrrolo(2,3-d)pyrimdin-5-yl)ethyl)benzoyl)glutamic acid
n-{4-[2-(2-amino-4-oxo-4,7-dihydro-1h-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-d-glutamic acid
NCGC00167517-01
nchembio.108-comp6
NCI60_035021
NSC698037
Pemetrexed
Pemetrexed (INN)
Pemetrexed [INN:BAN]
Pemetrexed disodium
Pemetrexed Disodium
Pemetrexed disodium (USAN)
Pemetrexed disodium [USAN]
Rolazar
ST51053024
Tifolar
UNII-04Q9AIZ7NO
UNII-2PKU919BA9
|
|
33 |
|
Dihydrotachysterol |
Approved |
Phase 2 |
|
67-96-9 |
5281010
5311071
|
Synonyms:
(1S,3E,4S)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylcyclohexan-1-ol
(1S,3E,4S)-3-[(2E)-2-[(3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylcyclohexan-1-ol
(3E)-3-[(2E)-2-[1-[(E)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylcyclohexan-1-ol
(3S,5E,7E,10S,22E)-9,10-secoergosta-5,7,22-trien-3-ol
(3Z)-3-[(2E)-2-[1-[(E)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylcyclohexan-1-ol
67-96-9
9,10-Secoergosta-5,7,22-trien-3beta-ol
A.T. 10
AC1NQXW4
AC1NS4C8
AC1NSJXZ
AC1NWALO
Antitanil
Anti-tetany substance 10
AT 10
AT-10
C06957
C28H46O
Calcamine
CHEBI:4591
CID5281010
CID5311071
CID5353584
CID5702045
D9257_FLUKA
D9257_SIGMA
DB01070
Dht Intensol
Dht(sub 2)
|
DHT2
Dichystrolum
Dihidrotaquisterol
Dihidrotaquisterol [INN-Spanish]
Dihydral
Dihydrotachysterin
dihydrotachysterol
Dihydrotachysterol [INN:BAN:JAN]
Dihydrotachysterol(sub 2)
Dihydrotachysterolum
Dihydrotachysterolum [INN-Latin]
Diidrotachisterolo
Diidrotachisterolo [DCIT]
Dygratyl
EINECS 200-672-7
HMS502L11
HSDB 3314
Hytakerol
IDI1_000869
LMST03010056
LS-148512
MolPort-003-941-198
NCGC00166147-01
NCGC00166147-02
Parterol
ST075187
Tachyrol
Tachystin
Vitamin D4
|
|
34 |
|
Nivolumab |
Approved |
Phase 2 |
|
946414-94-4 |
|
Synonyms:
|
35 |
|
Antibodies |
|
Phase 2 |
|
|
|
36 |
|
Immunoglobulins |
|
Phase 2 |
|
|
|
37 |
|
Antibodies, Monoclonal |
|
Phase 2 |
|
|
|
38 |
|
Chorionic Gonadotropin |
|
|
|
|
|
39 |
|
Vaccines |
|
|
|
|
|
Interventional clinical trials:
(show all 16)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
A Comparison of Single Versus Double Evacuation for Treatment of Hydatidiform Mole |
Recruiting |
NCT01630954
|
Phase 4 |
|
2 |
RCT on the Efficacy of Methotrexate for the Prevention of GTD |
Completed |
NCT01984099
|
Phase 3 |
Methotrexate;Vitamin B Complex |
3 |
Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia |
Completed |
NCT00003702
|
Phase 3 |
Methotrexate |
4 |
Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer |
Completed |
NCT00058071
|
Phase 3 |
amifostine trihydrate |
5 |
Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia |
Active, not recruiting |
NCT01535053
|
Phase 3 |
Leucovorin Calcium;Methotrexate |
6 |
Rescue Regimen and High Dose Methotrexate in Management of Presistent Gestational Trophoplastic Neoplasia |
Not yet recruiting |
NCT03280979
|
Phase 2, Phase 3 |
rescue regimen;high dose methotrxate |
7 |
Second Curettage in Treating Patients With Persistent Non-metastatic Gestational Trophoblastic Tumors |
Completed |
NCT00521118
|
Phase 2 |
|
8 |
A Trial for Patients With Gestational Trophoblastic Disease |
Completed |
NCT00190918
|
Phase 2 |
Pemetrexed |
9 |
Avelumab in Chemo-resistant Gestational Trophoblastic Neoplasias |
Recruiting |
NCT03135769
|
Phase 2 |
Avelumab administration at 10mg/kg |
10 |
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors |
Recruiting |
NCT02834013
|
Phase 2 |
|
11 |
Conformation of Beta Human Chorionic Gonadotropin During Chemotherapy for Choriocarcinoma |
Unknown status |
NCT00294177
|
|
|
12 |
Study of the Genetic and Epigenetic Causes of Recurrent Hydatidiform Moles |
Recruiting |
NCT01008501
|
|
|
13 |
Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule |
Recruiting |
NCT03785574
|
Not Applicable |
chemotherapy |
14 |
The French National Reference Centre of GTD |
Recruiting |
NCT02892877
|
|
|
15 |
BioThrax® (Anthrax) Vaccine in Pregnancy Registry |
Recruiting |
NCT01653392
|
|
|
16 |
Chemoresistance of Trophoblastic Tumors |
Not yet recruiting |
NCT03488901
|
|
|
|